Tender

NP31424 Clozapine Medicines

THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

This public procurement record has 1 release in its history.

Tender

05 Jul 2024 at 00:00

Summary of the contracting process

The Common Services Agency, also known as NHS National Services Scotland (NSS), located in Edinburgh, UK, has issued a tender titled "NP31424 Clozapine Medicines" for the supply of clozapine medicines to NHS Scotland. The procurement stage is currently in the tender process, with a deadline for submissions set for August 5, 2024. The tender falls under the health industry category and has an estimated value of £5,040,815. The procurement method used is an open procedure, and business entities eligible to compete should have expertise in supplying medical goods and services.

This tender opportunity presented by NSS for clozapine medicines can benefit businesses experienced in providing healthcare products and services. The tender offers the chance to secure a framework agreement with NHS Scotland for the supply of specific clozapine products along with patient testing routes. Businesses with a track record in pharmaceutical procurement are well-suited to compete in this tender stage. By meeting the technical and quality criteria outlined in the tender, organisations can potentially secure a long-term contract with NHS Scotland, contributing to business growth and market expansion within the healthcare sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

NP31424 Clozapine Medicines

Notice Description

Supply of clozapine medicines (alongside four (4) patient testing routes) to NHS Scotland. Goods and Services have been split into four (4) categories, each of which identified as a "Lot". The Authority intends awarding a single-supplier Framework Agreement per Lot. Further detail about each Lot is contained in Section II.2 of this Contract Notice.

Lot Information

Clozapine Orodispersible Tablets Sugar Free (Non-Core)

Supply of Clozapine Orodispersible Tablets Sugar Free (Non-Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Renewal: This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)

Supply of Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core), alongside one (1) patient testing route, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.. No value has been estimated for Lot 4 because (a) the requirement has never been used by Participating Authorities before, and (b) the requirement is speculative in nature. Award to Lot 4 is contingent on the Potential Framework Participant (a) being proposed for award to Lot 1 and (b) receiving a score of "pass" for the "Near Patient Testing (Capillary Blood Sampling)" award criterion.

Renewal: This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Clozapine Tablets (Core)

Supply of Clozapine Tablets (Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Clozapine Oral Suspension Sugar Free (Non-Care)

Supply of Clozapine Clozapine Oral Suspension Sugar Free (Non-Care), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.

Renewal: This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000771637
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL509286
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
OJEU - F2 - Contract Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£5,040,815 £1M-£10M
Lots Value
£5,040,605 £1M-£10M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
5 Jul 20241 years ago
Submission Deadline
5 Aug 2024Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")
Contact Name
Cameron Wright
Contact Email
cameron.wright@nhs.scot
Contact Phone
+44 7870831908

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Post Town
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-r6ebe6-0000771637-2024-07-05T00:00:00Z",
    "date": "2024-07-05T00:00:00Z",
    "ocid": "ocds-r6ebe6-0000771637",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-92",
            "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
            "identifier": {
                "legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
            },
            "address": {
                "streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent",
                "locality": "Edinburgh",
                "region": "UKM",
                "postalCode": "EH12 9EB"
            },
            "contactPoint": {
                "name": "Cameron Wright",
                "email": "cameron.wright@nhs.scot",
                "telephone": "+44 7870831908",
                "url": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
            }
        },
        {
            "id": "org-61",
            "name": "Sheriff Court House",
            "identifier": {
                "legalName": "Sheriff Court House"
            },
            "address": {
                "streetAddress": "27 Chambers Street",
                "locality": "Edinburgh",
                "postalCode": "EH1 1LB"
            },
            "contactPoint": {
                "email": "edinburgh@scotcourts.gov.uk",
                "faxNumber": "+44 1312252525",
                "url": "http://"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
        "id": "org-92"
    },
    "tender": {
        "id": "ocds-r6ebe6-0000771637",
        "title": "NP31424 Clozapine Medicines",
        "description": "Supply of clozapine medicines (alongside four (4) patient testing routes) to NHS Scotland. Goods and Services have been split into four (4) categories, each of which identified as a \"Lot\". The Authority intends awarding a single-supplier Framework Agreement per Lot. Further detail about each Lot is contained in Section II.2 of this Contract Notice.",
        "status": "active",
        "items": [
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "2"
            },
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "4"
            },
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "1"
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "id": "33600000",
                        "scheme": "CPV"
                    }
                ],
                "deliveryLocation": {
                    "description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
                },
                "deliveryAddresses": [
                    {
                        "region": "UKM"
                    }
                ],
                "relatedLot": "3"
            }
        ],
        "value": {
            "amount": 5040815,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "goods",
        "submissionMethod": [
            "electronicSubmission"
        ],
        "submissionMethodDetails": "https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html",
        "tenderPeriod": {
            "endDate": "2024-08-05T12:00:00Z"
        },
        "awardPeriod": {
            "startDate": "2024-08-05T12:00:00Z"
        },
        "documents": [
            {
                "id": "JUL509286",
                "documentType": "contractNotice",
                "title": "NP31424 Clozapine Medicines",
                "description": "Supply of clozapine medicines (alongside four (4) patient testing routes) to NHS Scotland. Goods and Services have been split into four (4) categories, each of which identified as a \"Lot\". The Authority intends awarding a single-supplier Framework Agreement per Lot. Further detail about each Lot is contained in Section II.2 of this Contract Notice.",
                "url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL509286",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "2",
                "title": "Clozapine Orodispersible Tablets Sugar Free (Non-Core)",
                "description": "Supply of Clozapine Orodispersible Tablets Sugar Free (Non-Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.",
                "status": "active",
                "value": {
                    "amount": 334525,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Technical (Services) -- Central Laboratory Testing",
                            "description": "12"
                        },
                        {
                            "type": "price",
                            "description": "40"
                        }
                    ]
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 1080
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
                }
            },
            {
                "id": "4",
                "title": "Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core)",
                "description": "Supply of Clozapine Tablets (Near Patient Testing (Capillary)) (Non-Core), alongside one (1) patient testing route, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.. No value has been estimated for Lot 4 because (a) the requirement has never been used by Participating Authorities before, and (b) the requirement is speculative in nature. Award to Lot 4 is contingent on the Potential Framework Participant (a) being proposed for award to Lot 1 and (b) receiving a score of \"pass\" for the \"Near Patient Testing (Capillary Blood Sampling)\" award criterion.",
                "status": "active",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Technical (Services) -- Central Laboratory Testing",
                            "description": "12"
                        },
                        {
                            "type": "price",
                            "description": "40"
                        }
                    ]
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 1080
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
                }
            },
            {
                "id": "1",
                "title": "Clozapine Tablets (Core)",
                "description": "Supply of Clozapine Tablets (Core), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.",
                "status": "active",
                "value": {
                    "amount": 4026980,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Technical (Services) -- Central Laboratory Testing",
                            "description": "12"
                        },
                        {
                            "type": "price",
                            "description": "40"
                        }
                    ]
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 1080
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
                }
            },
            {
                "id": "3",
                "title": "Clozapine Oral Suspension Sugar Free (Non-Care)",
                "description": "Supply of Clozapine Clozapine Oral Suspension Sugar Free (Non-Care), alongside three (3) patient testing routes, to NHS Scotland. The Authority intends to award this Lot as a single supplier framework agreement per Lot. Full details of Goods and Services and their volumes can be found within the ITT documents.",
                "status": "active",
                "value": {
                    "amount": 679100,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Technical (Services) -- Central Laboratory Testing",
                            "description": "12"
                        },
                        {
                            "type": "price",
                            "description": "40"
                        }
                    ]
                },
                "hasOptions": false,
                "submissionTerms": {
                    "variantPolicy": "notAllowed"
                },
                "contractPeriod": {
                    "durationInDays": 1080
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "This Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire."
                }
            }
        ],
        "lotDetails": {
            "maximumLotsBidPerSupplier": 2147483647
        },
        "bidOpening": {
            "date": "2024-08-05T12:00:00Z"
        },
        "contractTerms": {
            "hasElectronicPayment": true,
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed"
        },
        "coveredBy": [
            "GPA"
        ],
        "selectionCriteria": {
            "criteria": [
                {
                    "type": "suitability",
                    "description": "Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015."
                },
                {
                    "type": "technical",
                    "description": "(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the start date of the Framework Agreement. AND (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond. (e) Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark.",
                    "minimum": "(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. AND (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. AND (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency (\"NPSA\") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. AND (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder's carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions. (e) Confirmation that all devices tendered and associated ancillaries which are classed as medical devices will carry the appropriate declaration of conformity for the UK market and display a valid CE, CE UKNI or UKCA mark prior to the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Control."
                }
            ]
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "durationInDays": 90
            }
        },
        "techniques": {
            "hasFrameworkAgreement": true,
            "frameworkAgreement": {
                "maximumParticipants": 3,
                "periodRationale": "To provide a longer implementation period for the awarded Framework Participant(s) and a reasonable incentive for extension following a successful implementation."
            }
        },
        "classification": {
            "id": "33600000",
            "scheme": "CPV"
        },
        "reviewDetails": "The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a 'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
        "hasRecurrence": false,
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "language": "EN",
    "description": "The estimated values referred to in Section II.1.5 and within all Lots cover the thirty-six (36) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 26293. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that Potential Framework Participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this Framework Agreement. Potential Framework Participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential Framework Participants are required to summarise any proposed community benefits that will be developed and delivered as part of this Framework Agreement if successful or, alternatively, Potential Framework Participants confirm that they will engage with the NHS Scotland's Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:771637)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000771637"
        }
    ],
    "noticetype": "OJEU - F2 - Contract Notice"
}